ZBH Zimmer Biomet Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZBH

Price (delayed)

$119.75

Market cap

$24.56B

P/E Ratio

24.39

Dividend/share

$0.96

EPS

$4.91

Enterprise value

$29.91B

Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of ...

Highlights
The EPS has soared by 117% from the previous quarter
The net income has surged by 116% since the previous quarter
ZBH's quick ratio is down by 18% QoQ and by 13% YoY
The debt has increased by 5% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.zimmerbiomet.com/
Peers: BSX COO SYK EW

Key stats

What are the main financial stats of ZBH
Market
Shares outstanding
205.08M
Market cap
$24.56B
Enterprise value
$29.91B
Valuations
Price to earnings (P/E)
24.39
Price to book (P/B)
2.01
Price to sales (P/S)
3.38
EV/EBIT
23.6
EV/EBITDA
13.48
EV/Sales
4.05
Earnings
Revenue
$7.39B
EBIT
$1.27B
EBITDA
$2.22B
Free cash flow
$892.4M
Per share
EPS
$4.91
Free cash flow per share
$4.28
Book value per share
$59.72
Revenue per share
$35.43
TBVPS
$37.48
Balance sheet
Total assets
$21.5B
Total liabilities
$9.01B
Debt
$5.77B
Equity
$12.48B
Working capital
$1.75B
Liquidity
Debt to equity
0.46
Current ratio
1.61
Quick ratio
0.65
Net debt/EBITDA
2.41
Margins
EBITDA margin
30%
Gross margin
71.8%
Net margin
13.8%
Operating margin
17.3%
Efficiency
Return on assets
4.8%
Return on equity
8.3%
Return on invested capital
12%
Return on capital employed
6.8%
Return on sales
17.1%
Dividend
Dividend yield
0.8%
DPS
$0.96
Payout ratio
19.6%

ZBH stock price

How has the Zimmer Biomet Holdings stock price performed over time
Intraday
-1.17%
1 week
0.35%
1 month
-6.38%
1 year
-13.89%
YTD
-1.6%
QTD
-9.27%

Financial performance

How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$7.39B
Gross profit
$5.31B
Operating income
$1.28B
Net income
$1.02B
Gross margin
71.8%
Net margin
13.8%
The net income has surged by 116% since the previous quarter
The net margin has surged by 112% since the previous quarter
Zimmer Biomet Holdings's operating income has surged by 83% YoY and by 43% QoQ
Zimmer Biomet Holdings's operating margin has surged by 73% YoY and by 41% QoQ

Growth

What is Zimmer Biomet Holdings's growth rate over time

Valuation

What is Zimmer Biomet Holdings stock price valuation
ZBH P/E details
P/E
24.39
P/B
2.01
P/S
3.38
EV/EBIT
23.6
EV/EBITDA
13.48
EV/Sales
4.05
The EPS has soared by 117% from the previous quarter
ZBH's P/E is 50% lower than its last 4 quarters average of 48.9
The stock's P/B is 9% below its 5-year quarterly average of 2.2 and 4.3% below its last 4 quarters average of 2.1
ZBH's equity is up by 3.8% year-on-year
ZBH's price to sales (P/S) is 13% lower than its 5-year quarterly average of 3.9 and 9% lower than its last 4 quarters average of 3.7
The revenue has grown by 7% YoY

Efficiency

How efficient is Zimmer Biomet Holdings business performance
The ROIC has soared by 145% YoY and by 41% QoQ
The ROS has soared by 134% YoY and by 38% from the previous quarter
The ROA has soared by 118% from the previous quarter
Zimmer Biomet Holdings's return on equity has surged by 113% QoQ

Dividends

What is ZBH's dividend history
Dividend details
DPS
$0.96
Dividend yield
0.8%
Payout ratio
19.6%
Recent dividends

Financial health

How did Zimmer Biomet Holdings financials performed over time
The total assets is 139% higher than the total liabilities
The current ratio has contracted by 24% from the previous quarter and by 14% YoY
ZBH's quick ratio is down by 18% QoQ and by 13% YoY
The debt is 54% smaller than the equity
The debt has increased by 5% since the previous quarter
The debt to equity has grown by 4.5% since the previous quarter but it has declined by 2.1% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.